Seelos Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.25
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
4
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.10
|
0.00
|
0.10
|
100.00%
|
|
2022-12-31
|
-0.16
|
0.00
|
0.16
|
100.00%
|
|
2022-09-30
|
-0.10
|
-0.18
|
-0.08
|
-80.00%
|
|
2022-06-30
|
-0.14
|
-0.20
|
-0.06
|
-42.86%
|
|
2022-03-31
|
-0.18
|
-0.13
|
0.05
|
27.78%
|
|
2021-12-31
|
-0.11
|
-0.28
|
-0.17
|
-154.55%
|
|
2021-09-30
|
-0.08
|
-0.11
|
-0.03
|
-37.50%
|
|
2021-06-30
|
-0.12
|
-0.10
|
0.02
|
16.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.51
|
|
2021-12-31
|
-0.77
|
|
2020-12-31
|
-0.44
|
|
2019-12-31
|
-4.47
|
|
2018-12-31
|
-13.24
|
|
2017-12-31
|
-30.90
|
|
2016-12-31
|
-1.16
|
|
2015-12-31
|
-3.80
|
|
2014-12-31
|
-19.70
|
|
2013-12-31
|
-147.00
|
|
2012-12-31
|
-217.88
|
|
2011-12-31
|
-270.42
|
|
2010-12-31
|
-799.29
|
|
2009-12-31
|
-1629.53
|
|
2008-12-31
|
-281.70
|
|
2007-12-31
|
-450.00
|
|
2006-12-31
|
-585.00
|
|
2005-12-31
|
-1437.53
|
|
2004-12-31
|
-1755.22
|
|
2003-12-31
|
-6193.37
|
|
2001-12-31
|
-2880.00
|
|
2000-12-31
|
-5252.08
|